dc.contributor.author | Sipos, Bence | |
dc.date.accessioned | 2023-05-22T10:04:10Z | |
dc.date.available | 2023-05-22T10:04:10Z | |
dc.date.issued | 2022 | |
dc.identifier.issn | 2211-3428 | |
dc.identifier.uri | http://hdl.handle.net/10900/141302 | |
dc.language.iso | en | de_DE |
dc.publisher | Springer | de_DE |
dc.relation.uri | http://dx.doi.org/10.1007/s13402-022-00727-z | de_DE |
dc.subject.ddc | 570 | de_DE |
dc.subject.ddc | 610 | de_DE |
dc.title | Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy | de_DE |
dc.type | Article | de_DE |
utue.quellen.id | 20230202000000_00819 | |
utue.publikation.seiten | 1401-1419 | de_DE |
utue.personen.roh | Viol, Fabrice | |
utue.personen.roh | Sipos, Bence | |
utue.personen.roh | Fahl, Martina | |
utue.personen.roh | Clauditz, Till S. | |
utue.personen.roh | Amin, Tania | |
utue.personen.roh | Kriegs, Malte | |
utue.personen.roh | Nieser, Maike | |
utue.personen.roh | Izbicki, Jakob R. | |
utue.personen.roh | Huber, Samuel | |
utue.personen.roh | Lohse, Ansgar W. | |
utue.personen.roh | Schrader, Joerg | |
dcterms.isPartOf.ZSTitelID | Cellular Oncology | de_DE |
dcterms.isPartOf.ZS-Issue | 6 | de_DE |
dcterms.isPartOf.ZS-Volume | 45 | de_DE |
utue.fakultaet | 04 Medizinische Fakultät | de_DE |
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |